On April 7, 2025, the Ohio Legislature introduced House Bill 224, a significant piece of legislation aimed at expanding the authority of advanced practice registered nurses (APRNs) and certified midwives in administering glucagon, a critical medication for treating severe hypoglycemia. This bill seeks to enhance healthcare access and improve emergency responses for individuals at risk of diabetes-related complications.

The primary provision of House Bill 224 allows clinical nurse specialists, certified nurse-midwives, and certified nurse practitioners to furnish or prescribe injectable or nasally administered glucagon without the need for a prior examination of the patient. This change is particularly relevant in school settings and community health initiatives, where timely access to glucagon can be life-saving. The bill outlines specific regulations to ensure that the glucagon is provided in a manufactured dosage form, maintaining safety standards.

Supporters of the bill argue that it addresses a critical gap in emergency care, especially in schools and rural areas where medical professionals may not always be immediately available. By empowering nurses and midwives to act swiftly, the legislation aims to reduce the risk of severe health crises for individuals with diabetes.

However, the bill has sparked debates among healthcare professionals and lawmakers. Some critics express concerns about the potential for misuse or over-prescription of glucagon, emphasizing the need for adequate training and guidelines to ensure that these healthcare providers can make informed decisions. Additionally, there are discussions about the implications for liability, as the bill includes provisions that protect nurses and midwives from civil or criminal liability when acting in good faith under its guidelines.

The economic implications of House Bill 224 could be substantial. By potentially reducing emergency room visits and hospitalizations related to hypoglycemia, the bill may alleviate some financial burdens on the healthcare system. Furthermore, it could enhance the role of APRNs and midwives in the healthcare landscape, promoting a more collaborative approach to patient care.

As the bill moves through the legislative process, its supporters are optimistic about its potential to improve health outcomes for vulnerable populations. If passed, House Bill 224 could mark a significant step forward in empowering healthcare professionals and ensuring that critical medications are more readily available in emergency situations. The ongoing discussions surrounding the bill will likely shape its final form and implementation, reflecting the balance between expanding access to care and maintaining patient safety.